BO
Boundless Bio, Inc.
BOLD · NASDAQ
$2.60 -2.80% (-$0.07)
1M -10.96%
Market Cap $63.6M
P/E Ratio -
Div. Yield -
ROE 70.89%
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.96x
P/FFO N/A
P/S N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 70.89%
ROA 86.80%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 9.48x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
31 /100
Unstable EPS volatility 53.45%
Profitable years 0
Beta 0.38x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BOLD
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Zachary Hornby
Employees
28
Headquarters
San Diego
Upcoming events
05 NOV
Earnings
Upcoming earnings report